Edwards Lifesciences Corp

XNYS:EW 4:00:00 PM EDT

83.48

+0.79 (+0.96%)

: $83.90 +0.42 (+0.50%)

Market Cap (Intraday)	49.48B
Current PE	57.59
Forward PE	33
2yr Forward PE	29.6

See more stats

Estimates Current Quarter

Revenue	$1.55 Billion
Adjusted EPS	$0.61

See more estimates

10-Day MA	$80.12
50-Day MA	$77.58
200-Day MA	$75.17

See more pivots

Edwards Lifesciences Corp Stock, XNYS:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 15800

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.